Equities

Cannabis Bioscience International Holdings Inc

CBIH:PKC

Cannabis Bioscience International Holdings Inc

Actions
IndustrialsConstruction and Materials
  • Price (USD)0.0007
  • Today's Change0.000 / -12.50%
  • Shares traded7.33m
  • 1 Year change+75.00%
  • Beta-0.1807
Data delayed at least 15 minutes, as of Sep 20 2024 16:49 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in USDView more

In 2011, cash reserves at Cannabis Bioscience International Holdings Inc fell by 966.18k. However, Cash Flow from Investing totalled 400.55k, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company generated 348.50k in cash from operations while cash used for financing totalled 1.74m.
Cash flow per share0.6957
Price/Cash flow per share0.7915
Book value per share4.92
Tangible book value per share4.92
More ▼

Balance sheet in USDView more

Cannabis Bioscience International Holdings Inc has a Debt to Total Capital ratio of 6.31%, a higher figure than the previous year's 1.63%.
Current ratio0.699
Quick ratio0.6856
Total debt/total equity0.0714
Total debt/total capital0.0631
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.